GSK Will Submit Data To FDA On Lexiva’s Comparability To Kaletra
This article was originally published in The Pink Sheet Daily
Executive Summary
Results of a GSK/Vertex head-to-head clinical study indicate that Lexiva plus ritonavir is comparable to Abbott’s Kaletra in treatment-naive HIV patients.